Literature DB >> 23787918

Lifestyle factors associated with survival after colorectal cancer diagnosis.

T Boyle1, L Fritschi, C Platell, J Heyworth.   

Abstract

BACKGROUND: Aside from tumour stage and treatment, little is known about potential factors that may influence survival in colorectal cancer patients. The aim of this study was to investigate the associations between physical activity, obesity and smoking and disease-specific and overall mortality after a colorectal cancer diagnosis.
METHODS: A cohort of 879 colorectal cancer patients, diagnosed in Western Australia between 2005 and 2007, were followed up to 30 June 2012. Cox's regression models were used to estimate the hazard ratios (HR) for colorectal cancer-specific and overall mortality associated with self-reported pre-diagnosis physical activity, body mass index (BMI) and smoking.
RESULTS: Significantly lower overall and colorectal cancer-specific mortality was seen in females who reported any level of recent physical activity than in females reporting no activity. The colorectal cancer-specific mortality HR for increasing levels of physical activity in females were 0.34 (95% CI=0.15, 0.75), 0.37 (95% CI=0.17, 0.81) and 0.41 (95% CI=0.18, 0.90). Overweight and obese women had almost twice the risk of dying from any cause or colorectal cancer compared with women of normal weight. Females who were current smokers had worse overall and colorectal cancer-specific mortality than never smokers (overall HR=2.64, 95% CI=1.18, 5.93; colorectal cancer-specific HR=2.70, 95% CI=1.16, 6.29). No significant associations were found in males.
CONCLUSION: Physical activity, BMI and smoking may influence survival after a diagnosis of colorectal cancer, with more pronounced results found for females than for males.

Entities:  

Mesh:

Year:  2013        PMID: 23787918      PMCID: PMC3738138          DOI: 10.1038/bjc.2013.310

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Although colorectal cancer survival has improved in the last few decades, due partly to earlier detection and more effective treatments (Faivre-Finn ), colorectal cancer is still one of the major causes of cancer deaths in developed countries such as Australia (Australian Institute of Health and Welfare and Australasian Association of Cancer Registries, 2010; Ferlay ), The main predictors of colorectal cancer prognosis are tumour stage and treatment (Zlobec and Lugli, 2008), but little is known about other potential factors influencing survival in colorectal cancer patients. Lifestyle factors such as physical activity, obesity and cigarette smoking have been shown to be associated with the risk of colon and/or rectal cancers (World Cancer Research Fund and American Institute for Cancer Research, 2007; Boyle ), and in recent years the effect that these factors have on the prognosis of colorectal cancer has started to receive research attention. However, a recent review of the literature concerning the role of body mass index (BMI) and physical activity in colorectal cancer survival concluded that no firm conclusions could be drawn from the limited number of studies to date (Vrieling and Kampman, 2010). There is also limited research about the effect of smoking on colorectal cancer survival (Phipps ). The aim of this study was to investigate the association between modifiable lifestyle factors (pre-diagnosis physical activity, obesity and smoking) and disease-specific and overall survival after a diagnosis of colorectal cancer.

Materials and methods

The Western Australia Bowel Health Study

The participants in this cohort study were the 918 cases from a case–control study of colorectal cancer (The Western Australian Bowel Health Study; WABOHS) that was conducted in Western Australia between 2005 and 2007 (Clapin ). The patients in WABOHS were males and females aged between 40 and 79 years and were recruited from the Western Australia Cancer Registry soon after diagnosis. The median time from diagnosis to completion of the study questionnaire was 113 days (interquartile range 94–139 days). Of the 1544 eligible patients invited to participate in the WABOHS, 918 (59.5%) participated. Notification of all cancers, excluding non-melanoma skin cancer, is mandatory in Western Australia. The participants completed self-administered questionnaires that asked about lifestyle and medical risk factors for colorectal cancer, such as recreational physical activity, smoking history, height, weight, medication use and diet. Follow-up of the 918 patients began at the date of colorectal cancer diagnosis and ended at death or 30 June 2012, whichever came first. This survival study and the WABOHS received approval from the Human Research Ethics Committees at the Western Australian Department of Health and The University of Western Australia. Informed consent was obtained from all participants in the WABOHS.

Exposure measurements

To account for possible changes in behaviour as a result of colorectal cancer symptoms and/or diagnosis, BMI and smoking status were determined 1 year before study enrolment, and physical activity performed in the 1 year before study invitation was excluded. Information about recreational physical activity performed during three age periods (19–34 years, 35–50 years and ⩾51 years) was collected using a questionnaire based on others that have been shown to be reliable (Friedenreich ; Chasan-Taber ). More information about the coding of the physical activity data can be found elsewhere (Boyle ). In brief, data from the physical activity questionnaire were used to calculate total, moderate-intensity and vigorous-intensity metabolic-equivalent hours (MET-hours) per week for each age period. Activities were classified as moderate intensity or vigorous intensity according to their respective metabolic-equivalent value (Ainsworth ). Physical activity performed in the age period that the participant was in at the time of study enrolment was considered to be ‘recent recreational physical activity'. Total recent recreational physical activity was categorised as 0, 0.1–11.9, 12–29.9 and ⩾30 MET-hours per week. Recent moderate-intensity activity and recent vigorous-intensity activity were both categorised as 0, 0.1–5.9, 6–17.9 and ⩾18 MET-hours per week. A ‘lifetime recreational physical activity' variable was also created for total, moderate-intensity and vigorous-intensity physical activity. This variable categorised participants as always low activity or as high activity in one-, two- or all-age periods (Boyle ). We also looked at the association between resistance training and sedentary behaviour, and disease-specific and overall survival after a diagnosis of colorectal cancer. For resistance training, participants were categorised as having definitely, possibly or not performed resistance training over the lifetime, based on the name of the activities they listed on the physical activity questionnaire (Boyle ). Sedentary behaviour was measured in the occupational domain using a classification system based on job title (U.S. Department of Labor, 1991; Boyle ). This method of classifying occupational activity has been shown to have good agreement with self-reported job activity, particularly for sedentary (sitting) and light (standing) jobs (Boyle and Leong, 2012). Participants were classified as having spent 0 years, >0 years but <10 years, or ⩾10 years, in sedentary work. Information on height and weight 1 year before study enrolment was collected, and these data were used to calculate BMI. Body mass index was classified as normal weight (BMI<25 kg m−2), overweight (25⩽BMI<30 kg m−2) or obese (BMI⩾30 kg m−2). Very few participants (n=3) were underweight (BMI<17.5 kg m−2), so these participants were included in the normal weight category. Participants were classified as current, former or never smokers 1 year before study enrolment based on the self-reported information collected in the WABOHS.

Outcome measurement

Date and cause of deaths in the cohort were identified by linkage to the Western Australian Cancer Registry and the Western Australian Registry of Births, Deaths and Marriages. Cause of death was coded by the Australian Bureau of Statistics and/or the Western Australian Cancer Registry. Deaths that were coded as having been caused by colorectal cancer by either of these sources were classified as colorectal cancer-specific deaths in this study.

Statistical analysis

Cox's proportional hazard regression models were used to estimate the hazard ratios (HR) for colorectal cancer-specific mortality and overall mortality associated with physical activity, BMI and smoking. Age, sex, socioeconomic status, tumour stage and diabetes were considered to be potential confounders and were included as covariates in all models, and physical activity, BMI and smoking were mutually adjusted for each other. Socioeconomic status was based on the residential postcode and was classified using the Index of Relative Socio-economic Disadvantage from the Socio-Economic Indexes for Areas (Australian Bureau of Statistics, 2008). Information on tumour stage was collected from pathology or medical records and was classified as stage I, II, III or IV, or unknown. Participants were classified as having diabetes, high blood sugar levels or neither, based on self-report. Where appropriate, tests for trend were conducted by entering ordinal categorical variables into the model as continuous variables. Proportional hazards assumptions were tested using scaled Schoenfeld residuals (Schoenfeld, 1982). No violations of the proportionality assumption were observed for any of the covariates included in the colorectal cancer-specific or overall mortality models. We repeated the analyses stratified by sex, cancer site (colon or rectum) and cancer stage (stage I–III or stage IV). We also added interaction terms to non-stratified models to identify whether sex, cancer site or cancer stage significantly modified the associations between mortality and physical activity, BMI and/or smoking. Participants with unknown cancer stage were excluded from the stage-stratified and stage-exposure interaction analyses. Kaplan–Meier curves of colorectal cancer-specific survival across physical activity, BMI and smoking categories were generated for males and females separately. Missing data from one or more of the exposure variables resulted in 39 participants being excluded, leaving 879 participants in this study. Stata 11.2 (StataCorp, College Station, TX, USA) was used for all analyses.

Results

A total of 224 deaths (155 males, 69 females) occurred during follow-up, of which 187 (128 male, 59 females) were due to colorectal cancer. Median follow-up time was 5.9 years in those participants still alive at the end of follow-up, and 5.6 years among all participants. The demographic, lifestyle and clinical characteristics of the participants are shown in Table 1. The median age of the 879 participants (542 males, 337 females) at diagnosis was 65 years. Almost 15% of the participants reported doing no recent recreational physical activity, 10% were current smokers and 50% were former smokers. Almost 40% were overweight and ∼30% were obese 1 year before study enrolment.
Table 1

Lifestyle, demographic and clinical characteristics of the 879 patients

Characteristicn (%)
Sex
Female337 (38.3)
Male
542 (61.7)
Age, years (median, interquartile range)
65, 59–72
Total recent recreational physical activity (MET-hours per week; %)
0130 (14.8)
0.1–8.9229 (26.1)
9–23.9264 (30.0)
24–41.9
256 (29.1)
Body mass index 1 year ago (%)
<25283 (32.2)
25–29.9338 (38.5)
⩾30
258 (29.4)
Smoking status (%)
Never347 (39.5)
Former444 (50.5)
Current
88 (10.0)
Cancer site (%)
Colon558 (63.5)
Rectum
321 (36.5)
Stage (%)
One264 (30.0)
Two220 (25.0)
Three239 (27.2)
Four47 (5.3)
Unknown
109 (12.4)
Diabetes (%)
No701 (79.7)
High blood sugar49 (5.6)
Diabetes
129 (14.7)
Socioeconomic disadvantage (%)
1 (Most disadvantaged)153 (17.4)
2179 (20.4)
3177 (20.1)
4193 (22.0)
5 (Least disadvantaged)177 (20.1)

Abbreviation: MET-hours=metabolic-equivalent hours.

As expected, cancer stage was strongly associated with colorectal cancer-specific mortality (Table 2). The association between stage and all-cause mortality was also strong, although slightly attenuated compared with colorectal cancer mortality. Males had a poorer overall and colorectal cancer-specific mortality than females, although the difference was not statistically significant.
Table 2

Adjusted HR for the association between lifestyle, demographic and clinical characteristics and overall and colorectal cancer-specific mortality

  
Overall mortality
Colorectal cancer-specific mortality
 Person-time at risk (years)Deaths (n)HRa95% CIDeaths (n)HRa95% CI
Total recent MET-hours per week
0624481.00 331.00 
0.1–8.91197550.670.45, 0.99440.780.49, 1.25
9–23.91324630.750.51, 1.11560.990.63, 1.56
23.9–41.91324580.660.44, 0.98540.910.58, 1.42
Ptrend
 
 
 
0.116
 
 
0.940
Body mass index 1 year ago
<251471621.00 471.00 
25–29.91687941.330.95, 1.85821.511.04, 2.18
⩾301315681.260.88, 1.81581.330.89, 1.99
Ptrend
 
 
 
0.201
 
 
0.170
Smoking status
Never1772891.00 741.00 
Former22891040.870.64, 1.18870.940.67, 1.30
Current
412
31
1.31
0.86, 2.01
26
1.31
0.82, 2.09
Sex
Female1780691.00 591.00 
Male
2694
155
1.33
0.97, 1.80
128
1.24
0.89, 1.74
Stage
I1445281.00 181.00 
II1191431.911.18, 3.08322.211.24, 3.94
III1134894.072.66, 6.24795.413.23, 9.04
IV1423812.977.85, 21.443820.6511.61, 36.72
Unknown
561
26
2.60
1.52, 4.46
20
2.97
1.57, 5.64
Diabetes
No35351861.00 1541.00 
High blood sugar264110.760.41, 1.41100.810.42, 1.57
Diabetes
674
27
0.68
0.45, 1.03
23
0.75
0.48, 1.19
Socioeconomic disadvantage
1 (Most disadvantaged)754481.00 421.00 
2919380.810.53, 1.25320.780.49, 1.24
3917420.790.52, 1.20340.700.44, 1.10
41016490.920.61, 1.38380.810.52, 1.27
5 (Least disadvantaged)868471.070.70, 1.63410.990.63, 1.55

Abbreviations: CI=confidence intervals; HR=hazards ratio; MET-hours=metabolic-equivalent hours.

Adjusted for age, sex, socioeconomic status, tumour stage and diabetes. Physical activity, body mass index and smoking were all mutually adjusted for each other.

Physical activity

Participants who performed any amount of recent recreational physical activity reduced their risk of all-cause mortality compared with those who reported no recent physical activity; the HR for increasing levels of physical activity were 0.67 (95% CI=0.45, 0.99), 0.66 (95% CI=0.44, 0.98) and 0.75 (95% CI=0.51, 1.11) (Table 2). Sex-stratified analyses revealed a significant dose–response relationship between recent recreational physical activity and overall mortality in females (P=0.027), with significant risk reductions seen for women who performed any amount of recreational physical activity (Table 3). Recent recreational physical activity was not significantly associated with overall mortality in males. The inverse association between recent recreational physical activity and overall survival was not seen in participants with a stage IV colorectal cancer and appeared to be stronger in rectal cancer patients than in colon cancer patients, although there was no significant interaction between physical activity and cancer site.
Table 3

Adjusted HR for the association between lifestyle characteristics and overall and colorectal cancer-specific mortality, stratified by sex, cancer site and cancer stage

 Sex
Colorectal cancer site
Colorectal cancer stagea
 
Male
Female
Colon
Rectum
Stage I–III
Stage IV
 nHRb95% CInHRb95% CInHRb95% CInHRb95% CInHRb95% CInHRb95% CI
Overall mortality
Total recent MET-hours per week (%)
0
88
1.00
 
42
1.00
 
86
1.00
 
44
1.00
 
108
1.00
 
10
1.00
 
0.1–11.9
136
0.76
0.46, 1.25
93
0.45
0.22, 0.92
140
0.89
0.53, 1.49
89
0.38
0.19, 0.75
188
0.55
0.35, 0.86
13
0.95
0.30, 2.97
12–29.9
155
0.99
0.61, 1.58
109
0.38
0.19, 0.78
159
0.82
0.50, 1.37
105
0.63
0.33, 1.19
221
0.55
0.35, 0.85
10
3.44
1.01, 11.68
⩾30
163
0.83
0.51, 1.34
93
0.38
0.18, 0.80
173
0.75
0.45, 1.25
83
0.49
0.25, 0.95
206
0.49
0.31, 0.77
14
2.45
0.81, 7.39
Ptrend
 
 
0.731
 
 
0.027
 
 
0.247
 
 
0.267
 
 
0.008
 
 
0.043
Pinteraction0.1580.4680.007
Body mass index 1 year ago
<25
144
1.00
 
139
1.00
 
182
1.00
 
101
1.00
 
240
1.00
 
11
1.00
 
25–29.9
231
1.12
0.76, 1.65
107
1.95
1.05, 3.60
202
1.28
0.84, 1.95
136
1.32
0.75, 2.32
278
1.33
0.90, 1.96
19
1.37
0.55, 3.42
⩾30
167
1.01
0.65, 1.57
91
1.95
0.98, 3.86
174
1.05
0.67, 1.65
84
1.81
0.98, 3.34
205
1.34
0.88, 2.04
17
1.06
0.31, 3.57
Ptrend
 
 
0.964
 
 
0.046
 
 
0.866
 
 
0.058
 
 
0.167
 
 
0.854
Pinteraction
0.287
0.492
0.613
Smoking status
Never
150
1.00
 
197
1.00
 
227
1.00
 
120
1.00
 
287
1.00
 
19
1.00
 
Former
336
0.77
0.54, 1.10
108
1.04
0.60, 1.79
279
0.90
0.61, 1.32
165
0.82
0.50, 1.36
367
0.70
0.49, 1.01
22
2.85
1.09, 7.50
Current
56
1.05
0.62, 1.77
32
2.64
1.18, 5.93
52
1.42
0.81, 2.48
36
1.47
0.72, 2.98
69
1.40
0.84, 2.31
6
1.58
0.40, 6.25
Pinteraction
0.226
0.653
0.028
Colorectal cancer-specific mortality
Total recent MET-hours per week (%)
0
88
1.00
 
42
1.00
 
86
1.00
 
44
1.00
 
108
1.00
 
10
1.00
 
0.1–11.9
136
1.14
0.63, 2.06
93
0.34
0.15, 0.75
140
1.25
0.68, 2.31
89
0.37
0.17, 0.83
188
0.65
0.37, 1.13
13
0.95
0.30, 2.97
12–29.9
155
1.54
0.87, 2.71
109
0.37
0.17, 0.81
159
1.24
0.69, 2.24
105
0.73
0.35, 1.51
221
0.77
0.46, 1.29
10
3.44
1.01, 11.68
⩾30
163
1.35
0.77, 2.37
93
0.41
0.18, 0.90
173
1.17
0.65, 2.11
83
0.60
0.29, 1.24
206
0.74
0.44, 1.26
14
2.45
0.81, 7.39
Ptrend
 
 
0.209
 
 
0.143
 
 
0.727
 
 
0.709
 
 
0.558
 
 
0.043
Pinteraction
0.030
0.220
0.140
Body mass index 1 year ago
<25
144
1.00
 
139
1.00
 
182
1.00
 
101
1.00
 
240
1.00
 
11
1.00
 
25–29.9
231
1.36
0.87, 2.12
107
1.90
0.97, 3.72
202
1.41
0.89, 2.24
136
1.42
0.73, 2.77
278
1.53
0.98, 2.38
19
1.37
0.55, 3.42
⩾30
167
1.19
0.72, 1.96
91
1.79
0.84, 3.80
174
0.93
0.56, 1.55
84
2.40
1.21, 4.74
205
1.49
0.92, 2.40
17
1.06
0.31, 3.57
Ptrend
 
 
0.524
 
 
0.115
 
 
0.722
 
 
0.011
 
 
0.103
 
 
0.854
Pinteraction
0.758
0.114
0.323
Smoking status
Never
150
1.00
 
197
1.00
 
227
1.00
 
120
1.00
 
287
1.00
 
19
1.00
 
Former
336
0.78
0.52, 1.15
108
1.23
0.68, 2.23
279
0.95
0.63, 1.44
165
0.84
0.48, 1.49
367
0.72
0.49, 1.08
22
2.85
1.09, 7.50
Current
56
0.93
0.51, 1.68
32
2.70
1.16, 6.29
52
1.30
0.70, 2.44
36
1.63
0.76, 3.50
69
1.26
0.72, 2.20
6
1.58
0.40, 6.25
Pinteraction0.0780.8810.047

Abbreviations: CI=confidence intervals; HR=hazards ratio; MET-hours=metabolic-equivalent hours.

Excludes participants for whom cancer stage was unknown.

Adjusted for age, socioeconomic status, tumour stage and diabetes. Physical activity, body mass index and smoking were all mutually adjusted for each other.

The association between recent recreational physical activity and colorectal cancer-specific mortality was significantly modified by sex (P=0.03) (Table 3). Performing any amount of recreational physical activity significantly reduced the risk of dying from colorectal cancer in females; the HR for increasing levels of physical activity were 0.34 (95% CI=0.15, 0.75), 0.37 (95% CI=0.17, 0.81) and 0.41 (95% CI=0.18, 0.90). No significant association was found in males. In terms of intensity and timing, both recent and lifetime moderate-intensity physical activity were associated with a significantly reduced risk of overall and colorectal-cancer mortality in females (Table 4). Neither recent nor lifetime vigorous-intensity physical activity was significantly associated with mortality in females, and neither recent nor lifetime moderate-intensity or vigorous-intensity physical activity was significantly associated with mortality in males. Resistance training and sedentary work were not significantly associated with colorectal cancer-specific mortality or overall mortality in males or females (Table 4).
Table 4

Adjusted HR for the association between moderate-intensity and vigorous-intensity recent and lifetime physical activity, resistance training and sedentary work, and overall and colorectal cancer-specific mortality

  All-cause mortality
Colorectal cancer-specific mortality
 
 
Males
Females
Males
Females
 n (%)HRa95% CIHRa95% CIHRa95% CIHRa95% CI
Total recent moderate MET-hours per week
0182 (20.7)1.00 1.00 1.00 1.00 
0.1–5.9129 (14.7)0.770.43, 1.350.630.29, 1.350.950.49, 1.840.420.17, 1.02
6–17.9219 (24.9)0.680.42, 1.090.410.20, 0.851.000.59, 1.690.440.21, 0.94
⩾18
239 (39.7)
0.78
0.52, 1.18
0.41
0.21, 0.79
1.04
0.65, 1.68
0.40
0.20, 0.83
Total recent vigorous MET-hours per week
0626 (71.2)1.00 1.00 1.00 1.00 
0.1–5.997 (11.0)0.450.19, 1.040.540.24, 1.250.600.25, 1.420.450.17, 1.22
6–17.980 (9.1)0.460.21, 1.010.800.34, 1.890.560.25, 1.250.980.41, 2.35
⩾18
76 (8.7)
0.93
0.51, 1.70
1.55
0.57, 4.18
0.83
0.42, 1.63
2.06
0.73, 5.81
Lifetime total physical activity
Low in all-age periods216 (24.6)1.00 1.00 1.00 1.00 
High in one-age period177 (20.1)0.900.55, 1.480.520.26, 1.051.030.60, 1.790.730.35, 1.55
High in two-age periods153 (17.4)1.170.72, 1.890.830.40, 1.701.140.66, 1.991.130.50, 2.54
High in all-age periods
333 (37.9)
1.02
0.67, 1.56
0.48
0.26, 0.91
1.18
0.74, 1.89
0.65
0.33, 1.30
Lifetime moderate physical activity
Low in all-age periods225 (25.6)1.00 1.00 1.00 1.00 
High in one-age period187 (21.3)0.980.62, 1.550.750.37, 1.501.260.76, 2.101.070.50, 2.29
High in two-age periods185 (21.0)1.060.66, 1.690.730.36, 1.461.120.64, 1.940.900.41, 1.97
High in all-age periods
282 (32.1)
0.89
0.56, 1.41
0.31
0.15, 0.64
1.14
0.68, 1.90
0.41
0.18, 0.91
Lifetime vigorous physical activity
Low in all-age periods412 (46.9)1.00 1.00 1.00 1.00 
High in one-age period239 (27.2)0.940.64, 1.380.750.38, 1.471.030.68, 1.570.980.48, 1.99
High in two-age periods124 (14.1)0.870.51, 1.490.810.36, 1.820.880.48, 1.591.090.47, 2.52
High in all-age periods
104 (11.8)
0.76
0.41, 1.39
1.41
0.56, 3.56
0.70
0.35, 1.39
1.56
0.59, 4.08
Lifetime resistance training
None772 (87.8)1.00 1.00 1.00 1.00 
Possible56 (6.4)1.080.54, 2.150.310.09, 1.091.200.57, 2.530.310.08, 1.13
Definite
51 (5.8)
0.64
0.26, 1.60
0.46
0.13, 1.66
0.81
0.32, 2.05
0.50
0.14, 1.84
Years in sedentary work
0685 (77.9)1.00 1.00 1.00 1.00 
0.1–9.980 (9.1)0.720.34, 1.501.280.59, 2.770.900.43, 1.901.510.68, 3.34
⩾10114 (13.0)0.820.51, 1.321.840.66, 5.120.810.48, 1.351.600.52, 4.96

Abbreviations: CI=confidence intervals; HR=hazards ratio; MET-hours=metabolic-equivalent hours.

Adjusted for age, socioeconomic status, tumour stage and diabetes. Moderate-intensity and vigorous-intensity physical activity are mutually adjusted.

Body mass index

Compared with normal weight participants, overweight participants had a higher risk of colorectal cancer-specific mortality (HR=1.51, 95% CI=1.04, 2.18) and obese participants had a non-significant increased risk (HR=1.33, 95% CI=0.89, 1.99) (Table 2). The significant association between BMI and both overall mortality and colorectal cancer-specific mortality appeared to be limited to females and rectal cancer patients, although neither sex nor cancer site significantly modified the effect of BMI on mortality (Table 3).

Smoking

As with physical activity and BMI, the association between current smoking and mortality appeared to be more pronounced in females than in males (Table 3). Females who were current smokers had ∼2.5 times the risk of both overall mortality (HR=2.64, 95% CI=1.18, 5.93) and colorectal cancer-specific mortality (HR=2.70, 95% CI=1.16, 6.29). Being a former smoker was not associated with colorectal cancer-specific mortality or overall mortality in neither males nor females; however, it was significantly associated with mortality among people with stage IV colorectal cancer. Kaplan–Meier curves of colorectal cancer-specific survival across physical activity, BMI and smoking categories, for males and females separately, are presented in Figure 1.
Figure 1

Kaplan–Meier curves of colorectal cancer-specific survival across physical activity, BMI and smoking categories, by sex.

Discussion

In this study, we found that physical activity, BMI and smoking were significantly associated with all-cause mortality and/or colorectal cancer-specific mortality in females with colorectal cancer. For females, recent recreational physical activity was associated with a 50–60% reduced risk of both overall mortality and disease-specific mortality; being overweight or obese almost doubled the risk of overall and colorectal cancer-specific mortality, and being a current smoker increased the risk of overall and colorectal cancer-specific mortality by 2.5 times. The results were less pronounced in males, with no significant associations found between physical activity, BMI or smoking and mortality. Our finding of an inverse association between physical activity and mortality in female colorectal cancer patients adds to the growing body of literature, indicating that physical activity may have an important role in the prognosis of colorectal cancer. Seven previous studies have examined this association (Haydon ; Meyerhardt , 2006b, 2009; Baade ; Kuiper ; Campbell ). Five of these studies have investigated the effect of pre-diagnosis physical activity, with three studies finding a significant inverse association (Haydon ; Kuiper ; Campbell ) and two studies finding no association (Meyerhardt , 2006b). Post-diagnosis physical activity has been more consistently associated with survival among colorectal cancer patients than pre-diagnosis physical activity, with all of the six studies on this topic finding an inverse association, and risk reductions ranging from 40 to 70% (Meyerhardt , 2006b, 2009; Baade ; Kuiper ; Campbell ). A randomised controlled trial (the Colon Health and Life-Long Exercise Change trial) to confirm the results from this and other observational studies is currently underway (Courneya ). In our study, we found that physical activity was not inversely associated with mortality in patients with stage IV colorectal cancer. The only other study to investigate this reported similar findings (Haydon ), suggesting that physical activity does not increase survival in patients diagnosed with metastatic colorectal cancer. However, most previous studies on physical activity and survival in cancer patients have excluded people with metastatic disease (Ballard-Barbash ), and larger studies are needed to confirm this finding. The results of this study suggest that being overweight or obese is associated with poorer survival in colorectal cancer patients. This finding is consistent with much of the previous literature in this area (Vrieling and Kampman, 2010). It has been proposed that obesity may influence colorectal cancer survival by increasing insulin resistance and increasing the levels of insulin and insulin-like growth factors (Vrieling and Kampman, 2010). Conversely, physical activity may lead to increased survival in colorectal cancer patients by decreasing insulin resistance and lowering the concentrations of insulin and insulin-like growth factors (Vrieling and Kampman, 2010). Other possible mechanisms through which physical activity may influence survival in colorectal cancer patients include reduced weight and modulation of oxidative DNA damage (Davies ). Our finding of increased mortality in colorectal cancer patients who are current smokers is consistent with some (Munro ; Phipps , 2013), but not all (Yu ; Park ; McCleary ; Nordenvall ), previous research on this topic. Two studies have found that colon/colorectal cancer patients who were current smokers had poorer survival than those who were non-smokers (Munro ; Phipps ), whereas another study found that colon cancer-specific mortality, but not rectal cancer-specific mortality, was higher in current smokers than in never or former smokers (Phipps ). The remaining four studies found no association between current smoking and survival in colorectal cancer patients (Yu ; Park ; McCleary ; Nordenvall ). Moderate-intensity but not vigorous-intensity physical activity was significantly associated with mortality in this study. Only one of the previous six studies on physical activity and survival in colorectal cancer patients has taken intensity into account. That study found that intensity did not influence the effect of physical activity on survival in females (Kuiper ), suggesting that moderate-intensity physical activity is sufficient to improve survival. Lifetime physical activity as well as recent physical activity was associated with mortality in females in this study, suggesting that women who have been consistently physically active before a diagnosis of colorectal cancer have improved survival. Sedentary work and resistance training, both of which may be independent risk factors for colorectal cancer (Boyle, 2012; Boyle ), were not significantly associated with colorectal cancer-specific or overall survival in this study. It has been suggested that sedentary behaviour may potentially have an important role in morbidity and mortality in cancer patients (Lynch ), but only one previous study has investigated the association between sedentary behaviour and colorectal-cancer survival, with the results indicating a positive association between pre-and post-diagnosis leisure time sitting and both overall and colorectal cancer-specific mortality (Campbell ). No previous studies have examined the association between resistance training and survival in colorectal cancer patients. In this study, we found that the effects of physical activity, BMI and smoking on mortality in colorectal cancer patients were more pronounced in females than in males. Previous research indicates that the effect of obesity on mortality after a colorectal cancer diagnosis may differ according to sex, although the results are inconsistent (Vrieling and Kampman, 2010). A study by Meyerhardt also found that obesity may have a greater effect on mortality among female colorectal cancer patients than male colorectal cancer patients, whereas a study by Sinicrope found that class 1 obesity (BMI=30–34.9 kg m−2) was associated with increased mortality in female but not male colon cancer patients, but the opposite for class 2–3 obesity (BMI⩾35 kg m−2). However, several other studies report no sex differences (Dignam ; Baade ; Campbell ). Several plausible explanations for this potential gender disparity have been raised, including the different effects that obesity may have on leptin levels, insulin resistance, adult-onset diabetes, C-reactive protein levels and circulating oestrogen levels in females and males (Meyerhardt ). Five previous studies have conducted sex-specific analyses in relation to smoking and mortality in colorectal cancer patients. Three of these studies found no association in males (Park ; McCleary ; Nordenvall ) and/or females (McCleary ), whereas the remaining two studies found a significantly increased risk of colorectal cancer-specific mortality in female smokers but not male smokers, although there was no significant effect modification (Phipps , 2013). No prior studies have found that the effect of physical activity on mortality in colorectal cancer patients differ by sex. This study had several limitations that should be taken into account when interpreting the results. It is possible that the colorectal cancer patients who participated in this study were healthier (i.e., more likely to be physically active and less likely to be overweight or be a smoker) than those who did not take part. It is also possible that people with more advanced colorectal cancer were under-represented in this cohort, as they may have died before being invited to take part in the WABOHS. Participants were recruited from a population-based cancer registry soon after diagnosis, thus limiting potential patient loss and increasing the generalisibility of our results; however, 105 colorectal cancer patients died before they were invited to take part in the WABOHS. We also did not have any information about the treatment that the participants received for their colorectal cancer, so were not able to investigate its role as a possible confounder or effect modifier. However, as treatment is highly correlated with disease extent (stage), which we adjusted for in our analyses, it is probable that its inclusion in the analyses would have had little influence on our results. We were not able to investigate the effect of post-diagnosis physical activity, BMI or smoking as these data were not collected. Information about physical activity and sedentary behaviour was only collected in the recreational and occupational domains, respectively. Although the questions used in this study to measure physical activity, BMI and smoking were based on other reliable questionnaires, it is possible that some exposure misclassification may have occurred. However, any such exposure misclassification is likely to have been non-differential, and would therefore have attenuated the risk estimates seen in this study. With the exception of diabetes, we did not have information on co-morbidity, which may potentially be a confounder and/or mediator between lifestyle factors and mortality. Finally, we had limited statistical power to detect significant differences in stratified analyses, particularly those involving cancer stage. In summary, the results of this study, along with previous research, suggest that lifestyle factor such as physical activity, obesity and smoking may have an important role in the prognosis of colorectal cancer patients, particularly females. Larger studies and, where appropriate, randomised controlled trials are needed to confirm and improve our understanding of these associations.
  34 in total

1.  Reproducibility of a self-administered lifetime physical activity questionnaire among female college alumnae.

Authors:  Lisa Chasan-Taber; J Bianca Erickson; Jeanne W McBride; Philip C Nasca; Scott Chasan-Taber; Patty S Freedson
Journal:  Am J Epidemiol       Date:  2002-02-01       Impact factor: 4.897

Review 2.  The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature.

Authors:  Alina Vrieling; Ellen Kampman
Journal:  Am J Clin Nutr       Date:  2010-09       Impact factor: 7.045

3.  Recreational physical activity, body mass index, and survival in women with colorectal cancer.

Authors:  Josephina G Kuiper; Amanda I Phipps; Marian L Neuhouser; Rowan T Chlebowski; Cynthia A Thomson; Melinda L Irwin; Dorothy S Lane; Jean Wactawski-Wende; Lifang Hou; Rebecca D Jackson; Ellen Kampman; Polly A Newcomb
Journal:  Cancer Causes Control       Date:  2012-10-02       Impact factor: 2.506

4.  Obesity is an independent prognostic variable in colon cancer survivors.

Authors:  Frank A Sinicrope; Nathan R Foster; Daniel J Sargent; Michael J O'Connell; Cathryn Rankin
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

5.  Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147.

Authors:  Amanda I Phipps; Qian Shi; Polly A Newcomb; Garth D Nelson; Daniel J Sargent; Steven R Alberts; Paul J Limburg
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

6.  Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer.

Authors:  Caroline Nordenvall; Per J Nilsson; Weimin Ye; Therese M-L Andersson; Olof Nyrén
Journal:  Int J Cancer       Date:  2012-04-30       Impact factor: 7.396

7.  Colon cancer in France: evidence for improvement in management and survival.

Authors:  C Faivre-Finn; A-M Bouvier-Benhamiche; J M Phelip; S Manfredi; V Dancourt; J Faivre
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 8.  Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis.

Authors:  Terry Boyle; Tessa Keegel; Fiona Bull; Jane Heyworth; Lin Fritschi
Journal:  J Natl Cancer Inst       Date:  2012-08-22       Impact factor: 13.506

9.  Don't take cancer sitting down: a new survivorship research agenda.

Authors:  Brigid M Lynch; David W Dunstan; Jeff K Vallance; Neville Owen
Journal:  Cancer       Date:  2013-03-15       Impact factor: 6.860

Review 10.  The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature.

Authors:  N J Davies; L Batehup; R Thomas
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

View more
  37 in total

1.  Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.

Authors:  Brendan J Guercio; Sui Zhang; Fang-Shu Ou; Alan P Venook; Donna Niedzwiecki; Heinz-Josef Lenz; Federico Innocenti; Bert H O'Neil; James E Shaw; Blase N Polite; Howard S Hochster; James N Atkins; Richard M Goldberg; Kaori Sato; Kimmie Ng; Erin Van Blarigan; Robert J Mayer; Charles D Blanke; Eileen M O'Reilly; Charles S Fuchs; Jeffrey A Meyerhardt
Journal:  J Clin Oncol       Date:  2019-08-13       Impact factor: 44.544

2.  Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance).

Authors:  Amanda I Phipps; Qian Shi; Tyler J Zemla; Efrat Dotan; Sharlene Gill; Richard M Goldberg; Sheetal Hardikar; Balkrishna Jahagirdar; Paul J Limburg; Polly A Newcomb; Anthony Shields; Frank A Sinicrope; Daniel J Sargent; Steven R Alberts
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-21       Impact factor: 4.254

3.  Mobile App-Based Small-Group Physical Activity Intervention for Young African American Women: a Pilot Randomized Controlled Trial.

Authors:  Jingwen Zhang; John B Jemmott Iii
Journal:  Prev Sci       Date:  2019-08

4.  Health and lifestyle behaviors in colorectal cancer survivors with and without Lynch syndrome.

Authors:  Kirsten M Donato; Katelyn Moore; Wendy M Parker; Susan K Peterson; Ellen R Gritz; Christopher I Amos; Karen H Lu; Patrick M Lynch; Miguel A Rodriguez-Bigas; Y Nancy You; Allison M Burton-Chase
Journal:  J Community Genet       Date:  2019-04-23

5.  Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Authors:  Akiko Hanyuda; Sun A Kim; Alejandro Martinez-Fernandez; Zhi Rong Qian; Mai Yamauchi; Reiko Nishihara; Teppei Morikawa; Xiaoyun Liao; Kentaro Inamura; Kosuke Mima; Yin Cao; Xuehong Zhang; Kana Wu; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Ramesh A Shivdasani; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2015-11-17       Impact factor: 5.344

Review 6.  Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis.

Authors:  B Doleman; K T Mills; S Lim; M D Zelhart; G Gagliardi
Journal:  Tech Coloproctol       Date:  2016-06-24       Impact factor: 3.781

7.  Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium.

Authors:  J M Ordóñez-Mena; V Walter; B Schöttker; M Jenab; M G O'Doherty; F Kee; B Bueno-de-Mesquita; P H M Peeters; B H Stricker; R Ruiter; A Hofman; S Söderberg; P Jousilahti; K Kuulasmaa; N D Freedman; T Wilsgaard; A Wolk; L M Nilsson; A Tjønneland; J R Quirós; F J B van Duijnhoven; P D Siersema; P Boffetta; A Trichopoulou; H Brenner
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

8.  The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy.

Authors:  Alex Croese; Richard Gartrell; Richard Hiscock; Margaret Lee; Peter Gibbs; Ian Faragher; Justin Yeung
Journal:  Cancer Rep (Hoboken)       Date:  2021-02-07

9.  Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study.

Authors:  Dora Romaguera; Heather Ward; Petra A Wark; Anne-Claire Vergnaud; Petra H Peeters; Carla H van Gils; Pietro Ferrari; Veronika Fedirko; Mazda Jenab; Marie-Christine Boutron-Ruault; Laure Dossus; Laureen Dartois; Camilla Plambeck Hansen; Christina Catherine Dahm; Genevieve Buckland; María José Sánchez; Miren Dorronsoro; Carmen Navarro; Aurelio Barricarte; Timothy J Key; Antonia Trichopoulou; Christos Tsironis; Pagona Lagiou; Giovanna Masala; Valeria Pala; Rosario Tumino; Paolo Vineis; Salvatore Panico; H Bas Bueno-de-Mesquita; Peter D Siersema; Bodil Ohlsson; Karin Jirström; Maria Wennberg; Lena M Nilsson; Elisabete Weiderpass; Tilman Kühn; Verena Katzke; Kay-Tee Khaw; Nick J Wareham; Anne Tjønneland; Heiner Boeing; José R Quirós; Marc J Gunter; Elio Riboli; Teresa Norat
Journal:  BMC Med       Date:  2015-05-07       Impact factor: 8.775

10.  Associations between tissue-based CD3+ T-lymphocyte count and colorectal cancer survival in a prospective cohort of older women.

Authors:  Mosunmoluwa Oyenuga; Robert A Vierkant; Charles F Lynch; Thomas Pengo; Lori S Tillmans; James R Cerhan; Timothy R Church; DeAnn Lazovich; Kristin E Anderson; Paul J Limburg; Anna E Prizment
Journal:  Mol Carcinog       Date:  2020-11-17       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.